Around the IP Blogs


It's that time of the week again! Let's have a look at what happened in the IP world the past week...
Sunday again!?



On 20 January 2021 Birss J handed down what may be his last first instance decision before he takes his place in the Court of Appeal.  If that turns out to the case then Illumina Cambridge Limited v Latvia MGI Tech SIA and others is a substantial judgment to mark this departure.  In this case Illumina asserted MGI’s DNA sequencing systems, which MGI were just introducing to the UK, infringed five of its patents. Kluwer Patent Blog reported on the case.



The French Government presents the second report on content recognition tools on digital sharing platforms commissioned by the Conseil Supérieur de la Propriété Littéraire et Artistique (High Council for literary and artistic property – CSPLA). The new CSPLA report focuses on “proposals for the implementation of Article 17 of the EU copyright directive” and marks an important and timely contribution to the discussion about the implementation of Article 17. Kluwer Copyright Blog reported on the report.


Danielle Bernstein and her brand WeWoreWhat want the copyright infringement and unfair competition case filed against them tossed out of court. According to the motion to dismiss filed, counsel for the heavily-followed influencer and her brand claim that CV Collection, LLC d/b/a the Great Eros “improperly” filed suit against them in the Central District of California in what they say “appears to be an improper attempt at forum-shopping to avoid a pending federal action in New York” after they allegedly knocked off the signature pattern that appears on its product packaging. The Fashion Law reported on the case.


The relative contribution of a joint author is a factually complicated and difficult matter to assess. The re-trial of Martin and another v Kogan [2021] EWHC 24 (Ch) confirmed this to be the case. Kluwer Copyright Blog reported on the case.


Artificial Intelligence

The impact of Artificial Intelligence (AI) on intellectual property (IP) law undoubtedly ranks as one of the most-discussed topics of 2020 among legal academics and practitioners. On 20 October 2020, the European Parliament adopted a resolution on IP rights for the development of AI technologies. In parallel, on 25 November 2020, the European Commission published a commissioned study on challenges posed by AI to the European IP rights framework. Kluwer Patent Blog reported on this study.


Artificial intelligence (AI) is a rapidly growing sector of the life sciences industry, with broad-ranging applications in drug discovery, biotechnology, medical diagnosis, clinical trials, precision and personalized medicine and patient monitoring. IPWatchdog discussed strategies for IP protection of artificial intelligence in the life sciences industry.

Around the IP Blogs Around the IP Blogs Reviewed by Magdaleen Jooste on Sunday, February 07, 2021 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here:

Powered by Blogger.